Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.

[1]  S. Perry,et al.  Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. , 1995, Journal of the American College of Cardiology.

[2]  W E Haefeli,et al.  Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. , 1995, Circulation.

[3]  J. Loscalzo,et al.  Cardiovascular Effects of Inhaled Nitric Oxide in Patients With Left Ventricular Dysfunction , 1994, Circulation.

[4]  R. Kacmarek,et al.  Hemodynamic effects of inhaled nitric oxide in heart failure. , 1994, Journal of the American College of Cardiology.

[5]  S. Lundin,et al.  Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  P. Reddy,et al.  Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. , 1993, American heart journal.

[7]  A. Caplan,et al.  Task force 3: Recipient guidelines/prioritization , 1993 .

[8]  J. Coddens,et al.  Effects of dobutamine and/or nitroprusside on the pulmonary circulation in patients with pulmonary hypertension secondary to end-stage heart failure. , 1993, Journal of cardiothoracic and vascular anesthesia.

[9]  R. Mathew,et al.  Congestive Heart Failure Alters Receptor‐Dependent cAMP‐Mediated Relaxation of Canine Pulmonary Arteries , 1993, Circulation.

[10]  D. Gibson,et al.  Effects of intravenous milrinone on left ventricular function in ischemic and idiopathic dilated cardiomyopathy. , 1993, The American journal of cardiology.

[11]  G. Mudge,et al.  Cardiac Transplantation in the 1990s , 1993 .

[12]  D. Renlund,et al.  24th Bethesda conference: Cardiac transplantation. Task Force 5: Complications. , 1993, Journal of the American College of Cardiology.

[13]  H. Gray,et al.  Adenosine Infusion for the Reversal of Pulmonary Vasoconstriction in Biventricular Failure: A Good Test but a Poor Therapy , 1992, Circulation.

[14]  P. Reddy,et al.  Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  A Costard-Jäckle,et al.  Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. , 1992, Journal of the American College of Cardiology.

[16]  J. Schroeder,et al.  The influence of preoperative patient characteristics on early and late survival following cardiac transplantation. , 1991, Circulation.

[17]  J P Cooke,et al.  Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. , 1990, The American journal of physiology.

[18]  C. Dawson,et al.  4. Pulmonary Vascular Resistance (P:Q Relations) , 1990 .

[19]  M. Fishman.  The Pulmonary Circulation, Normal and Abnormal: Mechanisms, Management, and the National Registry , 1990 .

[20]  H. Drexler,et al.  Flow-dependent coronary artery dilatation in humans. , 1989, Circulation.

[21]  E. Blackstone,et al.  Pulmonary vascular resistance and the risk of heart transplantation. , 1988, The Journal of heart transplantation.

[22]  E. Blackstone,et al.  Analysis of morbid events and risk factors for death after cardiac transplantation. , 1988, Journal of the American College of Cardiology.

[23]  C. R. Smith,et al.  Elevated pulmonary vascular resistance and cardiac transplantation. , 1987, Circulation.

[24]  M. Cohen,et al.  In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides. , 1987, The Journal of pharmacology and experimental therapeutics.

[25]  P. Doubilet,et al.  Effects of heart rate on ventricular size, stroke volume, and output in the normal human fetus: a prospective Doppler echocardiographic study. , 1987, Circulation.

[26]  J. Drazen,et al.  Effects of milrinone on contractile responses of guinea pig trachea, lung parenchyma and pulmonary artery. , 1986, The Journal of pharmacology and experimental therapeutics.

[27]  P. Vanhoutte,et al.  Flow-induced release of endothelium-derived relaxing factor. , 1986, The American journal of physiology.

[28]  E. Braunwald,et al.  New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2. , 1986, The New England journal of medicine.

[29]  E. Braunwald,et al.  New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1. , 1986, The New England journal of medicine.

[30]  D. Baim,et al.  Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. , 1986, Circulation.

[31]  D. Johnson,et al.  Pharmacology of the bipyridines: amrinone and milrinone. , 1986, Circulation.

[32]  R. Cody,et al.  Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure. , 1986, Circulation.

[33]  M. Scheinman,et al.  Catheter ablation for treatment of tachyarrhythmias: present role and potential promise. , 1986, Circulation.

[34]  E. Braunwald,et al.  Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique. , 1986, Circulation.

[35]  D. Mancini,et al.  Systemic and regional hemodynamic effects of captopril and milrinone administered alone and concomitantly in patients with heart failure. , 1985, Circulation.

[36]  E. Braunwald,et al.  Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. , 1985, The Journal of clinical investigation.

[37]  E. Braunwald,et al.  Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure. , 1983, The New England journal of medicine.

[38]  R. Goldberg,et al.  Central and regional hemodynamic effects of intravenous isosorbide dinitrate, nitroglycerin and nitroprusside in patients with congestive heart failure. , 1981, The American journal of cardiology.

[39]  J. Bishop,et al.  The relation between pressure and flow in the pulmonary circulation in normal subjects and in patients with chronic bronchitis and mitral stenosis. , 1968, Cardiovascular research.